Results 111 to 120 of about 51,824 (150)

Medication-Related Osteonecrosis of the Jaw: An Evidence-Based 2025 Position Statement from a Korean Multidisciplinary Task Force. [PDF]

Endocrinol Metab (Seoul)
Kim JW, Kong SH, Kim JY, Kwak MK, Kim JY, Oh JH, Park HY, Kim B, Lee YK, Han JJ, Kim MY, Choi YJ, Kwon YD, Song KS, Kim BJ, Kim SJ, Baek SH, Lee DO, Choi HS, Kim HY, Kwon TG.   +20 more
europepmc   +1 more source

The Science behind the Guidelines: A Scientific Guide to the FAO Draft International Guidelines (December 2007) for the Management of Deep-Sea Fisheries in the High Seas and Examples of How the Guidelines may be Practically Implemented. [PDF]

, 2008
Clark, MR, Gjerde, KM, Hall-Spencer, JM, Rogers, AD   +3 more
core   +1 more source

Twenty Years of Continuous Bisphosphonate Use Leading to Atypical Bilateral Femoral Fractures: A Case Report. [PDF]

Am J Case Rep
Monachino AM, Berdini M, Tiburzi V, Procaccini R, Gigante AP.   +4 more
europepmc   +1 more source

Denosumab versus zoledronic acid for osteoporosis treatment in patients with primary biliary cholangitis (the DELTA Study): A multicenter, non-inferiority randomized trial. [PDF]

Hepatol Commun
Arase Y, Okubo T, Arai T, Abe M, Namisaki T, Uojima H, Matsumoto K, Kakisaka K, Kakisaka K, Setsu T, Mishima Y, Tsuruya K, Hirose S, Deguchi R, Shiraishi K, Atsukawa M, Ikegami T, Honda A, Terai S, Yoshiji H, Komori A, Tanaka A, Kagawa T.   +22 more
europepmc   +1 more source

Transient osteoporosis of the hip in a 17-year-old nonpregnant female: a case report. [PDF]

J Med Case Rep
Sheikdon AA, Ahmed AM, Ahmed OH.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Molecular imaging in oncology: Current impact and future directions

Ca-A Cancer Journal for Clinicians, 2022
Steven P Rowe, Martin G Pomper
exaly  

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

[New bone density conservation agents for osteoporosis under research and development: Ibandronate].

Nihon rinsho. Japanese journal of clinical medicine, 2008
Ikuko, Tanaka, Junko, Hashimoto, Hisaji, Oshima   +2 more
openaire   +1 more source

[New bone density conservation agents for osteoporosis under research and development: ED-71].

, 2007
Hiroshi Hagino
openalex  

[New bone density conservation agents for osteoporosis under research and development: Zoledronate].

Nihon rinsho. Japanese journal of clinical medicine, 2008
Seiki, Wada, Takeshi, Fukawa, Sadahiro, Kamiya   +2 more
openaire   +1 more source